SB
Shashi Bhushan Khobragade
About Shashi Bhushan Khobragade
Data last updated:
Shashi Bhushan Khobragade is a Director at Ceeyam Hospital Private Limited (since 2014) and Additional Director at Azimuth Drugs And Pharmaceuticals Private Limited (since 2014). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Ceeyam Hospital Private Limited at ₹26.38 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ceeyam Hospital Private Limited U85110KL1994PTC007932 | Director | 01 Mar 2014 | 1994 | ₹26.38 Cr (FY 2024) | Active |
| Azimuth Drugs And Pharmaceuticals Private Limited U24233KL2010PTC025508 | Additional Director | 15 Feb 2014 | 2010 | Active |
Board colleagues of Shashi Bhushan Khobragade
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shashi Bhushan Khobragade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shashi Bhushan Khobragade
Shashi Bhushan Khobragade currently holds 2 directorships: Ceeyam Hospital Private Limited (Director, since 01 Mar 2014, revenue ₹26.38 Cr (FY 2024)); Azimuth Drugs And Pharmaceuticals Private Limited (Additional Director, since 15 Feb 2014).
Shashi Bhushan Khobragade was first appointed on 15 Feb 2014 as Additional Director at Azimuth Drugs And Pharmaceuticals Private Limited.
The current boards of Shashi Bhushan Khobragade's companies include Abdul Salam Kalayam Kulath (Ceeyam Hospital Private Limited), Ahamed Kabeer Puthukkidi (Ceeyam Hospital Private Limited), Anilkumar (Ceeyam Hospital Private Limited), Hashim Cheriyandiyil (Ceeyam Hospital Private Limited), Ismail Puliyam Veettil (Ceeyam Hospital Private Limited), Kattadamool Pakrubaba Aboobacker Siddeek (Ceeyam Hospital Private Limited), among others.